Abbonarsi

A standardized imaging protocol is accurate in detecting recurrence after EMR - 20/04/17

Doi : 10.1016/j.gie.2016.06.031 
Lobke Desomer, MD 1, Nicholas Tutticci, MBBS 1, David J. Tate, MA (Cantab), MBBS, MRCP 1, Stephen J. Williams, MBBS 1, Duncan McLeod, MBBS 2, Michael J. Bourke, MBBS 1, 3,
1 Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, New South Wales, Australia 
2 Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, New South Wales, Australia 
3 Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia 

Reprint requests: Professor Michael J. Bourke, Director of Endoscopy, Department of Gastroenterology and Hepatology, Westmead Hospital, Suite 106a, 151-155 Hawkesbury Road, Westmead, Sydney, New South Wales 2143, Australia.Director of EndoscopyDepartment of Gastroenterology and HepatologyWestmead HospitalSuite 106a, 151-155 Hawkesbury RoadWestmeadSydney, New South Wales 2143Australia

Abstract

Background and Aims

EMR of large laterally spreading lesions (LSL) in the colon is a safe and effective alternative to surgery. Post-EMR scar assessment currently involves taking biopsy specimens of the scar to detect residual or recurrent adenoma (RRA). The accuracy of endoscopic imaging of the post-EMR scar is unknown. We aimed to determine the accuracy of a standardized imaging protocol in post-EMR scar assessment.

Methods

Prospective, single-center data from the Australian Colonic EMR study were analyzed. Consecutive patients undergoing first surveillance colonoscopy (SC1) after EMR of a large LSL were eligible. All scars were sequentially examined with high-definition white light (HD-WL) and narrow-band imaging (NBI) in a standardized fashion and then biopsies were performed. Endoscopic recurrence (recurrence at the post-EMR scar detected by systematic endoscopic assessment) was compared with the histologic findings.

Results

One hundred eighty-three post-EMR scars were included. Thirty of 183 (16.4%) were confirmed to have RRA histologically at SC1. Thirty-seven of 183 (20.2%) post-EMR scars demonstrated RRA endoscopically. The sensitivity and specificity of endoscopic RRA detection were 93.3% (95% confidence interval [CI], 77.9%-99.2%) and 94.1% (95% CI, 89.1%-97.3%), respectively. The positive predictive value was 75.7% (95% CI, 58.8%-88.2%) and the negative predictive value was 98.6% (95% CI, 95.1%-99.8%). The diagnostic accuracy was 94.0%. Sensitivity was higher for the combination of HD-WL and NBI as opposed to HD-WL alone (93.3% vs 66.7%). The specificity was high for both HD-WL and HD-WL + NBI (96.1% and 94.1%, respectively). Flat morphology of RRA was better seen with NBI (P = .002).

Conclusions

Endoscopic detection of RRA in the post-EMR scar is highly accurate using a standardized imaging protocol with HD-WL and NBI. This allows real-time, accurate detection of recurrence and its concurrent treatment, and raises the possibility that routine biopsy of the post-EMR scar may not be necessary.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : CI, ESCA, HD-WL, LSL, NBI, RRA, SC1, STSC


Mappa


 If you would like to chat with an author of this article, you may contact Dr Bourke at michael@citywestgastro.com.au.
 Dr. Lobke Desomer was supported by a grant from the Westmead Research Foundation. All authors disclosed no financial relationships relevant to this publication.


© 2017  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 85 - N° 3

P. 518-526 - marzo 2017 Ritorno al numero
Articolo precedente Articolo precedente
  • Per-oral video cholangiopancreatoscopy with narrow-band imaging for the evaluation of indeterminate pancreaticobiliary disease
  • Rawad Mounzer, Gregory L. Austin, Sachin Wani, Brian C. Brauer, Norio Fukami, Raj J. Shah
| Articolo seguente Articolo seguente
  • The benefit of narrow-band imaging after EMR of laterally spreading lesions
  • Jonathan Cohen

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.